Preoperative Systemic Immune-Inflammatory Index as a Predictive Biomarker for Lower Extremity Deep Vein Thrombosis after Breast Cancer Surgery: Stratified Nursing Intervention to Reduce Incidence
- PMID: 38104239
- PMCID: PMC10734205
- DOI: 10.12659/MSM.942087
Preoperative Systemic Immune-Inflammatory Index as a Predictive Biomarker for Lower Extremity Deep Vein Thrombosis after Breast Cancer Surgery: Stratified Nursing Intervention to Reduce Incidence
Abstract
BACKGROUND Lower extremity deep vein thrombosis (LEDVT), a common postoperative breast cancer complication, depends on multiple factors, such as systemic inflammation and immune status. We assessed the preoperative systemic immune-inflammatory index (SII) as a LEDVT risk predictor and did stratified nursing intervention based on it. MATERIAL AND METHODS A retrospective analysis was conducted on 552 patients who underwent breast cancer surgery from January 2019 to May 2020. Univariate and multivariate methods were used to screen independent risk factors for postoperative LEDVT, and effects of risk stratification and nursing intervention on the validation cohort were observed. RESULTS A total of 46 patients (8.3%) developed postoperative LEDVT. Compared with the control group, the LEDVT group had older age, higher proportion of menopause, higher preoperative Autar score, SII, and plasma D-dimer level, lower albumin level, and later postoperative pathological stage, with statistically significant differences (P<0.05). Multivariate logistic regression showed SII, plasma D-dimer, and menopause were independent predictors of postoperative LEDVT. ROC curve analysis showed SII had the strongest predictive ability, with an AUC of 0.714. Subsequently, 126 patients in the validation set were stratified according to the preoperative SII score, and intensified nursing intervention was implemented for high-risk patients, resulting in a significant reduction in the incidence of LEDVT (3.3% vs 8.3%, P=0.046). CONCLUSIONS Preoperative SII level can be used as an independent risk predictor of postoperative LEDVT in breast cancer patients. Applying it for risk stratification and implementing intensified nursing intervention for high-risk patients can significantly reduce the incidence of postoperative LEDVT.
Conflict of interest statement
Figures
Similar articles
-
Analysis of risk factors and construction of prediction model for lower extremity deep vein thrombosis after liver transplantation.Eur J Med Res. 2025 Feb 24;30(1):127. doi: 10.1186/s40001-025-02367-z. Eur J Med Res. 2025. PMID: 39994749 Free PMC article.
-
[Construction and validation of a predictive model for early occurrence of lower extremity deep venous thrombosis in ICU patients with sepsis].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):471-477. doi: 10.3760/cma.j.cn121430-20231117-00985. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38845492 Chinese.
-
Association between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis.Front Cardiovasc Med. 2023 Jun 16;10:1211294. doi: 10.3389/fcvm.2023.1211294. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37396591 Free PMC article.
-
Predictive Value of Systemic Immune Inflammation Index, Aggregate Index of Systemic Inflammation, and Systemic Inflammation Response Index in Lower Extremity Deep Venous Thrombosis Following Severe Trauma.Chin Med Sci J. 2024 Dec 23;39(4):241-248. doi: 10.24920/004411. Chin Med Sci J. 2024. PMID: 39789927 Chinese, English.
-
Analysis of risk factors and establishment of prediction model for lower extremity deep vein thrombosis after lumbar fusion surgery.BMC Surg. 2024 Dec 19;24(1):392. doi: 10.1186/s12893-024-02689-5. BMC Surg. 2024. PMID: 39702077 Free PMC article.
Cited by
-
Precision nursing and intermittent pneumatic compression significantly reduce perioperative deep vein thrombosis in post-surgical ovarian cancer patients.Am J Transl Res. 2024 Jun 15;16(6):2533-2543. doi: 10.62347/IWUD6619. eCollection 2024. Am J Transl Res. 2024. PMID: 39006274 Free PMC article.
References
-
- Mahajan A, Brunson A, White R, Wun T. The epidemiology of cancer-associated venous thromboembolism: An update. Semin Thromb Hemost. 2019;45(4):321–25. - PubMed
-
- Trott T, Bowman J. Diagnosis and management of pulmonary embolism. Emerg Med Clin North Am. 2022;40(3):565–81. - PubMed
-
- Falanga A, Ay C, Di Nisio M, et al. ESMO Guidelines Committee. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34(5):452–67. - PubMed
-
- Giaquinto AN, Sung H, Miller KD, et al. Breast Cancer Statistics, 2022. Cancer J Clin. 2022;72(6):524–41. - PubMed
-
- Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline update. J Clin Oncol. 2020;38(5):496–520. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical